FDA Adverse Event Injury Summary report: N

TRULIANT TIB IMP CR INS SLOPE+ SZ 3.5 9 MM

MDR report key: 17316772 · Received July 13, 2023

Report

Report Number
1038671-2023-01641
Event Type
Injury
Date Received
July 13, 2023
Date of Event
June 14, 2023
Report Date
January 13, 2025
Manufacturer
EXACTECH, INC.
Product Code
JWH
UDI-DI
10885862306852
PMA / PMN Number
K152170
Removal / Correction Number
Z-0023-2022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SECTION D10: CONCOMITANT PRODUCTS TRULIANT CR CEM FEM CR CEM LEFT SZ 3.5 (CAT# 02-020-13-0235 / SERIAL# (B)(6)) TRULIANT TIB FIT TRAY CEM SZ 3.5F / 3.5T (CAT# 02-022-45-3535 / SERIAL# (B)(6)) THREE PEG PATELLA 32MM (CAT# 200-02-32 / SERIAL# (B)(6)) ADDITIONAL INFORMATION, INCLUDING THE PRODUCT INVESTIGATION, WILL BE SUBMITTED WITHIN 30 DAYS OF RECEIPT.

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL AND/OR CORRECTED INFORMATION. THE REVISION REPORTED WAS LIKELY THE RESULT OF PROSTHESIS WEAR. ADDITIONAL REASONS FOR THE REPORTED REVISION MAY BE INCLUSION OF THE POLYETHYLENE IN THE PACKAGING RECALL. POTENTIAL CONTRIBUTIONS OF USER AND PATIENT-RELATED CONSIDERATIONS TO THE EVENT COULD NOT BE ASSESSED AS THE DEVICES WERE NOT AVAILABLE FOR EVALUATION AND RADIOGRAPHS WERE NOT PROVIDED. IF ANY FURTHER INFORMATION IS OBTAINED THAT WOULD CHANGE OR ALTER ANY INFORMATION PROVIDED, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY.

Description of Event or Problem · 0

AS REPORTED, APPROXIMATELY 3.5 YEARS POST INITIAL TKA, THE 50 Y/O FEMALE PATIENT HAD A REVISION FOR AN UNKNOWN REASON. PATIENT HAD A RECALL DEVICE. NO ADDITIONAL INFORMATION AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2209612 TRULIANT TIB IMP CR INS SLOPE+ SZ 3.5 9 MM PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED JWH EXACTECH, INC. TRULIANT TIB IMP CR INS SLOPE+ SZ 3.5 9 MM UNK 10885862306852

Patients

Seq Age Sex Outcome Treatment
1 50 YR Female Required Intervention